Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 26, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2027

Conditions

Prostate Cancer

Interventions

DEVICE

IRE & MRgRT

Subjects will undergo Irreversible electroporation(IRE) followed by Magnetic resonance guided radiotherapy (MRgRT)

Trial Locations (1)

Weill Cornell Medicine, New York

All Listed Sponsors

lead

Weill Medical College of Cornell University

OTHER